KORU Medical Systems, Inc. (NASDAQ:KRMD – Get Free Report) was the recipient of a significant growth in short interest in February. As of February 28th, there was short interest totalling 506,600 shares, a growth of 34.8% from the February 13th total of 375,900 shares. Based on an average daily volume of 174,800 shares, the short-interest ratio is currently 2.9 days. Approximately 1.2% of the shares of the company are sold short.
Wall Street Analyst Weigh In
Several research analysts have weighed in on the stock. Lake Street Capital upped their target price on shares of KORU Medical Systems from $4.00 to $5.00 and gave the stock a “buy” rating in a research report on Tuesday, January 14th. Piper Sandler restated a “neutral” rating and set a $4.50 target price on shares of KORU Medical Systems in a research report on Friday, February 14th. Craig Hallum upped their target price on shares of KORU Medical Systems from $5.00 to $6.00 and gave the stock a “buy” rating in a research report on Friday, January 17th. Finally, B. Riley upgraded shares of KORU Medical Systems to a “strong-buy” rating in a research report on Thursday, March 13th. One analyst has rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Buy” and an average price target of $4.70.
Check Out Our Latest Analysis on KORU Medical Systems
KORU Medical Systems Trading Down 1.7 %
Hedge Funds Weigh In On KORU Medical Systems
Large investors have recently bought and sold shares of the stock. Topline Capital Management LLC purchased a new position in shares of KORU Medical Systems in the 4th quarter valued at $16,660,000. First Light Asset Management LLC raised its stake in shares of KORU Medical Systems by 5.7% in the 4th quarter. First Light Asset Management LLC now owns 5,915,434 shares of the company’s stock valued at $22,774,000 after acquiring an additional 316,509 shares during the period. Empire Financial Management Company LLC purchased a new position in shares of KORU Medical Systems in the 3rd quarter valued at $259,000. 683 Capital Management LLC purchased a new position in shares of KORU Medical Systems in the 4th quarter valued at $340,000. Finally, Russell Investments Group Ltd. raised its stake in shares of KORU Medical Systems by 41,806.9% in the 4th quarter. Russell Investments Group Ltd. now owns 67,051 shares of the company’s stock valued at $258,000 after acquiring an additional 66,891 shares during the period. Hedge funds and other institutional investors own 58.60% of the company’s stock.
KORU Medical Systems Company Profile
KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.
Recommended Stories
- Five stocks we like better than KORU Medical Systems
- There Are Different Types of Stock To Invest In
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- 3 Best Fintech Stocks for a Portfolio Boost
- 3 Must-Own Stocks to Build Wealth This Decade
- Stock Splits, Do They Really Impact Investors?
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for KORU Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KORU Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.